Clinical Trial Update: A Study of Hydroxypropyl Guar Galactomannan 0.25% (HPGG) Versus Vehicle in Dry Eye Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing Hydroxypropyl Guar Galactomannan 0.25% to vehicle in dry eye patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye

Drugs mentioned

• Hydroxypropyl Guar Galactomannan 0.25% (hydroxypropyl guar galactomannan)

Snippet

Sponsor: Alcon Research | Conditions: Dry Eye | Phase 2 | Status: COMPLETED